Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Hypertension
NCT00765674Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of aliskiren, amlodipine, hydrochlorothiazide in hypertension (HTN), sponsored by Novartis. Started Sep 2008; status: completed.
02
Drugs
aliskirenamlodipinehydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00765674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00765674.